Two ways to get your patients started on AUSTEDO

Write a 30-day prescription and remind pharmacy to use a Free Trial Voucher

Example of patient reaching 24-mg daily dose of AUSTEDO

Gray prescription pad outlining HD chorea titration. Week 1: 6 mg QD (6 mg/day), Week 2: 6 mg BID (12 mg/day),
Week 3: 9 mg BID (18 mg/day),
Week 4:12 mg BID (24 mg/day).

Starting dose of AUSTEDO will differ if switching from tetrabenazine.

  • After 30 days, increase by 6 mg/day weekly until desired symptom control is achieved1

For sampling patients—provide a 2-week Starter Pack, along with a 30-day prescription and remind pharmacy to use a Free Trial Voucher

A white pill
                    package that has
                    the first two weeks
                    of AUSTEDO
                    treatment for new
  • The 30-day prescription following use of Starter Pack can start at Week 3 dosage of 9 mg BID1
  • Pharmacy should be notified that patients have been sampled

Free Trial Vouchers and Copay Coupons available for patients starting on AUSTEDO at

Certain restrictions apply for Free Trial Vouchers and Copay Coupons. Copay Coupons are not available for patients eligible for Medicare, Medicaid, or any other form of government insurance coverage. Terms and conditions on

Teva’s Shared Solutions® is committed to helping patients gain affordable access

Shared Solutions®
                  offers patient
                  support. Support,

Here to help with matters such as a change or loss of insurance, support for the
uninsured, benefits investigation, and financial assistance eligibility determination.

To request services from Shared Solutions®:

  • Fax the completed form to Shared Solutions® at 1-844-257-6126
  • Once the form is received and verified, and a benefits investigation has been conducted, your patient will receive a welcome phone call from Shared Solutions®

For payers who may need to appeal a denial of coverage or establish medical necessity:

REFERENCE: 1. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Parsippany, NJ, Teva Neuroscience, Inc.